Scientific Reports 5: Article number: 1651210.1038/srep16512; published online: November182015; updated: January292016
This Article contains errors.
In Table 2, the number of genes associated with 1, 3 and 7 dpi were incorrectly presented. The correct Table 2 appears below as Table 1.
Table 1.
Dpi | H5N8 | Log2 FC | p-value | H5N1 | Log2 FC | p-value |
---|---|---|---|---|---|---|
1 dpi | Myosin, light polypeptide 2, regulatory, cardiac, slow | −8.3 | 0.00005 | Heat shock 70 kDa protein 1A | −3.35 | 0.00005 |
Immunoglobulin heavy variable 1-73 | −7.25 | 0.00005 | Unknown | −3.21 | 0.00115 | |
Natriuretic peptide type A | −4.48 | 0.00005 | Phosphoenolpyruvate carboxykinase 1, cytosolic | −2.9 | 0.00005 | |
Heat shock 70 kDa protein 1A | −3.83 | 0.00005 | Neutrophilic granule protein | −2.71 | 0.00005 | |
Myosin binding protein C, cardiac | −3.23 | 0.00005 | Chemokine (C-X-C motif) ligand 5 | −2.39 | 0.00075 | |
Unknown | −3.19 | 0.00005 | Unknown | −2.35 | 0.00005 | |
Chloride channel calcium activated 3 | −3.05 | 0.00005 | Neuronal PAS domain protein 2 | −2.34 | 0.00005 | |
LINE-1 reverse transcriptase homolog | −3.01 | 0.0031 | Monoacylglycerol O-acyltransferase 1 | −2.21 | 0.0014 | |
Corin | −2.9 | 0.00005 | Arachidonate 15-lipoxygenase | −2.16 | 0.00005 | |
Phosphoenolpyruvate carboxykinase 1, cytosolic | −2.79 | 0.00005 | Ankyrin repeat and EF-hand domain containing 1 | −2.04 | 0.00005 | |
3 dpi | Immunoglobulin heavy variable 1-73 | −3.97 | 0.00005 | ATPase, H+ transporting, lysosomal V1 subunit B1 | −4.55 | 0.00005 |
Unknown | −3.96 | 0.00085 | Unknown | −4.25 | 0.0026 | |
Thyroid stimulating hormone receptor | −2.74 | 0.00025 | Immunoglobulin heavy variable 1-73 | −4.08 | 0.00005 | |
Family with sequence similarity 124, member B | −2.5 | 0.00005 | Cytochrome P450 4A12A | −3.51 | 0.00005 | |
Neuronal PAS domain protein 2 | −2.34 | 0.00005 | Cadherin-like 26 | −3.43 | 0.00005 | |
A disintegrin-like and metallopeptidase | −2.3 | 0.00005 | Ig kappa chain V-IV region S107B | −3.42 | 0.0055 | |
Heat shock 70 kDa protein 1A | −2.28 | 0.00005 | Cellular retinoic acid binding protein I | −3.15 | 0.0081 | |
Solute carrier family 17 (sodium phosphate), member 2 | −2.17 | 0.00075 | CD209a antigen | −3.09 | 0.00005 | |
phosphoenolpyruvate carboxykinase 1, cytosolic | −2.14 | 0.00005 | Unknown | −3.06 | 0.00005 | |
Ring finger protein 112 | −2.05 | 0.0018 | Neuronal PAS domain protein 2 | −3.03 | 0.00005 | |
7 dpi | Myosin, light polypeptide 2, regulatory, cardiac, slow | −9.79 | 0.00005 | Hemoglobin alpha, adult chanin 2 | −7.44 | 0.00005 |
Bone morphogenetic protein 10 | −5.08 | 0.00005 | Hemoglobin, beta adult t chain | −7.25 | 0.00005 | |
Unknown | −3.95 | 0.0001 | Hemoglobin alpha, adult chain 1 | −7.01 | 0.00005 | |
CD209a antigen | −3.67 | 0.00005 | Aminolevulinic, beta adult s chain | −6.75 | 0.00005 | |
Unknown | −3.55 | 0.00005 | Haemoglobin, beta adult s chain | −6.7 | 0.00005 | |
Unknown | −3.38 | 0.00005 | Unknown | −6.39 | 0.00005 | |
Cytochrome P450, family 1, subfamily a, polypeptide 1 | −3.27 | 0.00005 | Fatty acid binding protein 1, liver | −5.6 | 0.00265 | |
Unknown | −3.23 | 0.00395 | Lactase-like | −5.58 | 0.0198 | |
Cadherin-like 26 | −3.12 | 0.00005 | Unknown | −5.12 | 0.00005 | |
Immunoglobulin heavy variable 1-73 | −3.1 | 0.00005 | Solute carrier family 17 (sodium phosphate), number 2 | −5.08 | 0.00005 |
In addition, the Figure labels were omitted in Figures 4 and 5. The correct Figures 4 and 5 appear below as Figs 1 and 2 respectively.
And lastly, the Acknowledgements section is incomplete.
“This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea.(Grant No. A103001).”
should read:
“This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea.(Grant No. A103001) and grant number P30GM114737, from the Centers of Biomedical Research Excellence program of the National Institute of General Medical Sciences, National Institutes of Health.”